227 related articles for article (PubMed ID: 31839941)
1. Twice daily cefazolin is effective for treatment of serious methicillin-sensitive
Birrell MT; Fuller A
Ther Adv Infect Dis; 2019; 6():2049936119882847. PubMed ID: 31839941
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Ceftriaxone in the Treatment of Methicillin-Susceptible
Ganguly A; de la Flor C; Alvarez K; Brown LS; Mang NS; Smartt J; King H; Perl TM; Filizola H; Bhavan KP
Ann Pharmacother; 2023 Apr; 57(4):425-431. PubMed ID: 35942602
[TBL] [Abstract][Full Text] [Related]
3. Clinical Outcomes of an Innovative Cefazolin Delivery Program for MSSA Infections in OPAT.
Herrera-Hidalgo L; Luque-Márquez R; de Alarcon A; Guisado-Gil AB; Gutierrez-Gutierrez B; Navarro-Amuedo MD; Praena-Segovia J; Carmona-Caballero JM; Fraile-Ramos E; Gutierrez-Valencia A; Lopez-Cortes LE; Gil-Navarro MV
J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329878
[TBL] [Abstract][Full Text] [Related]
4. Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore.
Chan M; Ooi CK; Wong J; Zhong L; Lye D
BMC Infect Dis; 2017 Jul; 17(1):474. PubMed ID: 28683717
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Ceftriaxone Compared With Cefazolin or Nafcillin/Oxacillin for Outpatient Therapy for Methicillin-Sensitive
Hamad Y; Nickel KB; Olsen MA; George IA
Open Forum Infect Dis; 2024 Feb; 11(2):ofad662. PubMed ID: 38352150
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Outpatient Parenteral Antimicrobial Therapy With Ceftriaxone for Methicillin-Susceptible
Hamad Y; Connor L; Bailey TC; George IA
Open Forum Infect Dis; 2020 Sep; 7(9):ofaa341. PubMed ID: 32908944
[TBL] [Abstract][Full Text] [Related]
7. Clinical Effectiveness of Continuous Infusion Flucloxacillin in the Outpatient Parenteral Antimicrobial Therapy (OPAT) Setting in a UK Hospital: A Service Evaluation.
Clarkson AM; Snape S
Antibiotics (Basel); 2024 Feb; 13(2):. PubMed ID: 38391538
[TBL] [Abstract][Full Text] [Related]
8. Outpatient parenteral antimicrobial therapy for the treatment of methicillin-susceptible Staphylococcus aureus: a comparison of cefazolin and ceftriaxone.
Winans SA; Luce AM; Hasbun R
Infection; 2013 Aug; 41(4):769-74. PubMed ID: 23686435
[TBL] [Abstract][Full Text] [Related]
9. Review of the first comprehensive outpatient parenteral antimicrobial therapy program in a tertiary care hospital in Japan.
Hase R; Yokoyama Y; Suzuki H; Uno S; Mikawa T; Suzuki D; Muranaka K; Hosokawa N
Int J Infect Dis; 2020 Jun; 95():210-215. PubMed ID: 32205285
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting.
Youngster I; Shenoy ES; Hooper DC; Nelson SB
Clin Infect Dis; 2014 Aug; 59(3):369-75. PubMed ID: 24785233
[TBL] [Abstract][Full Text] [Related]
11. Implementation of a cefazolin-based stewardship pathway for methicillin-susceptible Staphylococcus aureus bloodstream infections paired with infectious diseases consultation.
Lee BJ; Rao SN; Wang SK; Lee JY; Lakada IY; Gilbert EM; Barr VO; Postelnick MJ; Sutton SH; Zembower TR; Bolon M; Scheetz MH; Rhodes NJ
Int J Antimicrob Agents; 2017 May; 49(5):650-654. PubMed ID: 28279787
[TBL] [Abstract][Full Text] [Related]
12. Supervised self-administration of outpatient parenteral antibiotic therapy: a report from a large tertiary hospital in Australia.
Subedi S; Looke DF; McDougall DA; Sehu MM; Playford EG
Int J Infect Dis; 2015 Jan; 30():161-5. PubMed ID: 25603999
[TBL] [Abstract][Full Text] [Related]
13. [The first trial of OPAT (outpatient parenteral antimicrobial therapy) with continuous infusions in Japan].
Hase R; Hosokawa N; Uno S; Mikawa T; Uwamino Y; Muranaka K
Kansenshogaku Zasshi; 2014 May; 88(3):269-74. PubMed ID: 24974449
[TBL] [Abstract][Full Text] [Related]
14. Comparative outcomes of cefazolin versus antistaphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a post hoc analysis of a prospective multicentre French cohort study.
Lecomte R; Bourreau A; Deschanvres C; Issa N; Le Turnier P; Gaborit B; Chauveau M; Leroy AG; Le Tourneau T; Caillon J; Camou F; Boutoille D
Clin Microbiol Infect; 2021 Jul; 27(7):1015-1021. PubMed ID: 32950711
[TBL] [Abstract][Full Text] [Related]
15. Safety and feasibility of outpatient parenteral antimicrobial therapy for patients with spinal infection.
Kilinc F; Setzer M; Behmanesh B; Jussen D; Gessler F; Keil F; Kempf VAJ; Kessel J; Czabanka M; Prinz V
Sci Rep; 2023 Apr; 13(1):6863. PubMed ID: 37100824
[TBL] [Abstract][Full Text] [Related]
16. [Outpatient Parenteral Antimicrobial Therapy (OPAT) with Elastomeric Pumps in Collaboration with Home-visit Nursing Services in Japan: Experience of the First 10 Patients].
Hase R; Uno S; Miyoshi K; Fujita K; Suzuki H; Suzuki D; Mikawa T; Muranaka K; Hosokawa N
Kansenshogaku Zasshi; 2015 Sep; 89(5):567-73. PubMed ID: 26630787
[TBL] [Abstract][Full Text] [Related]
17. A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia.
Davis JS; Turnidge J; Tong S
Int J Antimicrob Agents; 2018 Aug; 52(2):297-300. PubMed ID: 29499317
[TBL] [Abstract][Full Text] [Related]
18. Evaluate the Effectiveness of Outpatient Parenteral Antimicrobial Therapy (OPAT) Program in Saudi Arabia: A Retrospective Study.
Al Shareef HJ; Al Harbi A; Alatawi Y; Aljabri A; Al-Ghanmi MA; Alzahrani MS; Algarni MA; Khobrani A; Haseeb A; AlSenani F; Elrggal ME
Antibiotics (Basel); 2022 Mar; 11(4):. PubMed ID: 35453192
[TBL] [Abstract][Full Text] [Related]
19. Antistaphylococcal penicillins vs. cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus infective endocarditis: a quasi-experimental monocentre study.
Lefèvre B; Hoen B; Goehringer F; Sime WN; Aissa N; Alauzet C; Jeanmaire E; Hénard S; Filippetti L; Selton-Suty C; Agrinier N;
Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2605-2616. PubMed ID: 34383175
[TBL] [Abstract][Full Text] [Related]
20. Cefazolin versus cloxacillin as definitive antibiotic therapy for methicillin-susceptible Staphylococcus aureus spinal epidural abscess: a retrospective cohort study.
Bai AD; Findlater A; Irfan N; Singhal N; Loeb M
Int J Antimicrob Agents; 2021 Nov; 58(5):106429. PubMed ID: 34469802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
